Lymphoma is cancer that begins in cells of the lymph system. The two main types of lymphoma are Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). Period analysis was used to calculate 5-year relative survival in 2002-2006, overall and by gender, age and histology. Overall 5-year relative survival for patients with NHL in Germany in 2002-2006 was 62.8% and in the US was 65.1%. Survival was higher for women than for men, at 65.2% for women and 60.7% for men. The following are some of the common subtypes of NHL:Burkitt's lymphoma, Diffuse large cell lymphoma, Follicular lymphoma, MALT lymphoma, Mantle cell lymphoma.
A study is looking at a new type of scan called magnetic resonance spectroscopy (MRS) to see if it can help to predict which type of treatment will work best for individual patients. MRS gives information about the activity inside a cancer, by looking at chemical changes. Researchers want to collect information from the scans and create a database so that they can see how patients' individual biological differences affect how well particular treatments work for them. The following imaging studies should be obtained in a patient suspected of having NHL:Chest radiography, Upper GI series with small bowel follow-through: In patients with head and neck involvement and those with a GI primary lesion, CT scanning of the neck, chest, abdomen, and pelvis.